MedPath

CODEINE CONTIN 100MG CONTROLLED RELEASE TAB

CODEINE CONTIN 100MG CONTROLLED RELEASE TAB

Approved
DIN Number

02163748

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

purdue pharma

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02163748
AIG Number0153086004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05DA04 CODEINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE)Active
Strength: 100 MG
Monograph: CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.